Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Total Liabilities (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Total Liabilities of $8.43 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 42.2% from $14.59 million a year earlier and down 25.1% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Total Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Total Liabilities came in at $13.04 million, down 6.5% from FY2025.

  • Annual Total Liabilities shows a five-year compound annual growth rate of -4.4% (FY2021 to FY2026).
  • In prior fiscal years, Vistagen Therapeutics' Total Liabilities was $13.95 million in FY2025 (+48.9%), $9.37 million in FY2024 (+4.0%), $9.01 million in FY2023 (-9.3%) and $9.93 million in FY2022 (-39.1%).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Total Liabilities since fiscal Q3 2024.
  • On a year-over-year basis, Total Liabilities has declined in each of the last three quarters, with growth averaging 19.4% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was fiscal Q2 2026, with growth of 53.2%; the weakest was fiscal Q2 2023, with a decline of 44.1%.
  • According to Business Quant data, Total Liabilities for the three prior fiscal quarters was $11.26 million (Q1 2027), $13.04 million (Q4 2026) and $14.14 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.31 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 107.80 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 115.90 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 152.26 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 87.83 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 38.37 Bn
9 Gsk 193.54 Bn 176.38 Bn - 70.58 Bn
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 8.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.43 Mn
Jun 30, 2026 11.26 Mn
Mar 31, 2026 13.04 Mn
Dec 31, 2025 14.14 Mn
Sep 30, 2025 14.59 Mn
Jun 30, 2025 12.16 Mn
Mar 31, 2025 13.95 Mn
Dec 31, 2024 11.19 Mn
Sep 30, 2024 9.52 Mn
Jun 30, 2024 8.75 Mn
Mar 31, 2024 9.37 Mn
Dec 31, 2023 7.78 Mn
Sep 30, 2023 6.55 Mn
Jun 30, 2023 8.18 Mn
Mar 31, 2023 9.01 Mn
Dec 31, 2022 9.03 Mn
Sep 30, 2022 11.10 Mn
Jun 30, 2022 12.67 Mn
Mar 31, 2022 9.93 Mn
Dec 31, 2021 10.56 Mn
API Access

Vistagen Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY